Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00144846 · ClinicalTrials.gov registry record · Phase 3
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT00144846: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00144846 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00144846, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study evaluates the effect of cumulative dose administration of albuterol sulfate inhalation aerosol delivered with valved holding chamber and facemask. This is a four week study in birth to 23 month old subjects who are experiencing acute wheezing due to obstructive airways disease.
Interventions
- DRUG albuterol sulfate inhalation aerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-02 |
| Phase | Phase 3 |
What the finished NCT00144846 record still lists
NCT00144846 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which albuterol sulfate inhalation aerosol is the first listed.
NCT00144846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00144846 about?
NCT00144846 is a clinical study titled "Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children". This study evaluates the effect of cumulative dose administration of albuterol sulfate inhalation aerosol delivered with valved holding chamber and facemask. This is a four week study in birth to 23 month old subjects who are experiencing acute wheezing due to obstructive airways disease.
What is the current status of trial NCT00144846?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2004-09. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00144846?
The interventions under investigation include: albuterol sulfate inhalation aerosol (DRUG).
Who is sponsoring clinical trial NCT00144846?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00144846's enrollment target sits among peer trials
80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia